High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
2022 · Nature Biotechnology · 207 citations
https://doi.org/10.1038/s41587-022-01418-8
A
Alexis Talbot
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
1.4K
Citations
18
h-index
32
i10-index
Alexis Talbot is an academic researcher from Gladstone Institutes. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 18, co-authored 104 publications.
ORCID: 0000-0001-6734-413XPapers by this author
worksAn evolved AAV variant enables efficient genetic engineering of murine T cells
2023 · Cell · 82 citations
https://doi.org/10.1016/j.cell.2022.12.022
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
2025 · Blood Advances · 2 citations
https://doi.org/10.1182/bloodadvances.2025017597
Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study
2025 · Clinical Lymphoma Myeloma & Leukemia · 1 citations
https://doi.org/10.1016/j.clml.2025.05.015
35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience
2025 · Blood Cancer Journal · 1 citations
https://doi.org/10.1038/s41408-025-01387-6
Data from Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple Myeloma
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.7160223.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat